91 | IntegrinsIBA
01/2022
-
01/2004 |
89 | Peptides (Polypeptides)IBA
01/2022
-
01/2004 |
74 | Pharmaceutical PreparationsIBA
02/2022
-
12/2005 |
44 | Integrin alphaVbeta3IBA
02/2010
-
01/2004 |
41 | arginyl-glycyl-aspartic acidIBA
08/2014
-
01/2004 |
34 | Proteins (Proteins, Gene)FDA Link
01/2022
-
06/2008 |
27 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021
-
01/2004 |
25 | GoldIBA
12/2021
-
04/2011 |
25 | LigandsIBA
11/2021
-
03/2005 |
23 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
-
04/2007 |
22 | Contrast MediaIBA
01/2022
-
11/2004 |
21 | Biological ProductsIBA
01/2022
-
02/2008 |
20 | 1-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2021
-
05/2014 |
20 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016
-
11/2006 |
19 | Radioisotopes (Radionuclides)IBA
01/2022
-
01/2004 |
18 | Reactive Oxygen Species (Oxygen Radicals)IBA
09/2022
-
01/2016 |
18 | Cell Adhesion MoleculesIBA
07/2012
-
01/2004 |
17 | Photosensitizing Agents (Photosensitizers)IBA
12/2021
-
06/2011 |
17 | Bombesin Receptors (Bombesin Receptor)IBA
03/2021
-
03/2006 |
17 | AcidsIBA
01/2019
-
10/2004 |
17 | cyclic arginine-glycine-aspartic acid peptideIBA
09/2012
-
01/2004 |
15 | EnzymesIBA
08/2022
-
12/2009 |
15 | Coloring Agents (Dyes)IBA
03/2020
-
11/2004 |
15 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
06/2019
-
05/2008 |
15 | BombesinIBA
01/2018
-
08/2004 |
14 | ProdrugsIBA
02/2022
-
01/2017 |
14 | Glucose (Dextrose)FDA LinkGeneric
01/2022
-
05/2006 |
14 | Biomarkers (Surrogate Marker)IBA
11/2021
-
01/2008 |
14 | Small Interfering RNA (siRNA)IBA
03/2021
-
09/2006 |
13 | AntigensIBA
06/2022
-
10/2011 |
13 | ErbB Receptors (EGF Receptor)IBA
04/2019
-
06/2007 |
12 | Evans Blue (Blue, Evans)FDA Link
01/2022
-
07/2009 |
12 | IonsIBA
01/2021
-
01/2016 |
12 | Matrix Metalloproteinases (MMPs)IBA
05/2020
-
11/2006 |
11 | PolymersIBA
02/2022
-
10/2016 |
11 | AlbuminsIBA
01/2022
-
07/2014 |
11 | Therapeutic UsesIBA
01/2021
-
08/2010 |
11 | Firefly LuciferasesIBA
01/2017
-
11/2006 |
10 | Monoclonal AntibodiesIBA
11/2017
-
09/2006 |
10 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2012
-
11/2006 |
10 | Integrin alphaVIBA
05/2008
-
01/2004 |
9 | AntibodiesIBA
06/2022
-
12/2005 |
9 | IronIBA
12/2021
-
02/2011 |
9 | Oxygen (Dioxygen)IBA
06/2021
-
01/2017 |
9 | Exenatide (Byetta)FDA Link
04/2021
-
01/2012 |
8 | MetalsIBA
08/2022
-
01/2016 |
8 | VaccinesIBA
01/2022
-
01/2017 |
8 | Glutathione (Reduced Glutathione)IBA
04/2021
-
02/2016 |
8 | MicellesIBA
03/2021
-
04/2011 |
8 | Chelating AgentsIBA
01/2018
-
06/2007 |
8 | Ferritins (Ferritin)IBA
01/2018
-
02/2011 |
8 | Fluorescent Dyes (Fluorescent Probes)IBA
01/2017
-
11/2004 |
7 | RNA (Ribonucleic Acid)IBA
01/2022
-
05/2014 |
7 | Hydroxyl RadicalIBA
12/2021
-
08/2012 |
7 | Glucagon-Like Peptide-1 ReceptorIBA
04/2021
-
01/2012 |
7 | RadiopharmaceuticalsIBA
10/2020
-
12/2006 |
7 | Metal-Organic FrameworksIBA
10/2020
-
01/2017 |
7 | CopperIBA
01/2020
-
03/2016 |
7 | DNA (Deoxyribonucleic Acid)IBA
12/2019
-
12/2014 |
7 | Carbon Nanotubes (Carbon Nanotube)IBA
05/2014
-
08/2008 |
6 | alfatide IIIBA
01/2022
-
04/2012 |
6 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022
-
01/2011 |
6 | SolutionsIBA
01/2022
-
01/2017 |
6 | NanovaccinesIBA
01/2022
-
03/2016 |
6 | Silicon Dioxide (Silica)FDA LinkGeneric
04/2021
-
06/2012 |
6 | Cisplatin (Platino)FDA LinkGeneric
01/2021
-
10/2014 |
6 | Molecular Probes (Molecular Probe)IBA
01/2020
-
05/2007 |
6 | ferric oxide (iron oxide)IBA
01/2020
-
08/2008 |